Ginkgo Bioworks Holdings Inc (DNA) stock saw a modest uptick, ending the day at $10.83 which represents a slight increase of $0.63 or 6.18% from the prior close of $10.2. The stock opened at $10.31 ...

Enfusion (ENFN – Research Report) received a Hold rating and price target from William Blair analyst Dylan Becker today. The company’s shares ...

William Blair boosted their FY2024 earnings per share estimates for Certara in a research note issued on Wednesday, January 15th. William Blair analyst M. Smock now expects that the company will earn ...

A three-judge panel of the 3rd Circuit Court of Appeals this week reversed an order by a district judge in Pittsburgh affirming Pennsylvania laws that prohibit adults under the age of 21 from ...

Among the flock of Evangelical leaders attending President-elect Donald Trump s second inauguration in Washington, D C , next ...

For investors looking for opportunities in fintech, SoFi presents an interesting case. Here's where analysts think the stock ...

Enovix Corp (ENVX) stock saw a modest uptick, ending the day at $10.95 which represents a slight increase of $0.17 or 1.58% from the prior close of $10.78. The stock opened at $10.75 and touched a low ...

The Supreme Court upheld a US law that bans TikTok on Jan. 19 unless it is sold to an owner not controlled by a foreign ...

Portillo’s has never been one to follow the worn path in quick service. It hasn’t engaged in the “value wars” or materially ...

Fintel reports that on January 15, 2025, William Blair initiated coverage of Affirm Holdings (NasdaqGS:AFRM) with a ...

William Blair analyst Andrew Jeffrey initiated coverage of both SoFi Technologies (SOFI) and Affirm (AFRM) with Outperform ratings. The firm ...

Neumora Therapeutics’ phase 3 fail was worse than analysts feared. | Neumora Therapeutics’ phase 3 fail was worse than ...